The relationship between history of thyroid diseases and risk of in-hospital cardiovascular outcomes in patients with atrial fibrillation: Findings From the CCC-AF (Improving Care for Cardiovascular Disease in China-Atrial Fibrillation) Project

Dong, Mengya; Xu, Chenbo; Zhang, Lisha; Deng, Feng; Zhang, Zhan-yi; Shu, Shan; Yuan, Zuyi; Zhou, Juan

doi:10.1016/j.medcli.2020.04.048

Cited by 4 publications

(4 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hyperthyroidism is the most common ve modifiable endocrine disorder that significantly increases the risk of AF. 175,176 Overt hyperthyroidism, subclinical hyperthyroidism, and high normal euthyroidism increase the of AF by about 42%, 31%, and 12%, respectively. 177,178 It is thought that the main factor triggering AF is the free thyroxine (FT4) level.…”

Section: Thyroid Disease and Other Endocrine Disordersmentioning

confidence: 95%

Section: Thyroid Disease and Other Endocrine Disordersmentioning

confidence: 99%

“…179 Moreover, a recent study revealed that history of hyperthyroidism was an independent risk factor of in-hospital major adverse cardiac events (MACE) in AF patients. 176 Usually, AF spontaneously reverts to sinus rhythm when the euthyroid state is restored and AF associated with hyperthyroidism has a lower recurrence rate after electrical cardioversion compared with AF not associated with hyperthyroidism. 180 Based on observations, hypothyroidism has had a neutral effect or decreased the risk of AF but associated with higher bleeding events in patients with AF.…”

Section: Endocrine Disordersmentioning

confidence: 99%

See 2 more Smart Citations

Current Evidence on Prevention of Atrial Fibrillation: Modifiable Risk Factors and the Effects of Risk Factor Intervention

Akboğa

İnanç

Keskin

et al. 2021

Cardiology in Review

View full text Add to dashboard Cite

Atrial fibrillation (AF) is one of the most encountered arrhythmias in clinical practice. It is also estimated that the absolute AF burden may increase by greater than 60% by 2050. It is inevitable that AF will become one of the largest epidemics in the world and may pose a major health problem for countries. Although AF rarely causes mortality in the acute period, it causes a significant increase in mortality and morbidity, including a fivefold increase in the risk of stroke, a twofold increase in dementia, and a twofold increase in myocardial infarction in the chronic period. Despite all the advances in the treatment of AF, it is better understood day by day that preventing AF may play a key role in reducing AF and its related complications. Modification of the main modifiable factors such as quitting smoking, abstaining from alcohol, changing eating habits, and exercise seems to be the first step in preventing AF. The strict adherence to the treatment process of secondary causes predisposing to AF such as DM, hypertension, obesity, and sleep apnea is another step in the prevention of AF. Both an individual approach and global public health campaigns can be highly beneficial to reduce the risk of AF. In this review, we aimed to summarize the current evidence on the relationship between modifiable risk factors and AF, and the impact of possible interventions on these factors in preventing or reducing the AF burden in the light of recently published guidelines and studies.

show abstract

Section: Thyroid Disease and Other Endocrine Disordersmentioning

confidence: 95%

Section: Thyroid Disease and Other Endocrine Disordersmentioning

confidence: 99%

Section: Endocrine Disordersmentioning

confidence: 99%

See 1 more Smart Citation

Current Evidence on Prevention of Atrial Fibrillation: Modifiable Risk Factors and the Effects of Risk Factor Intervention

Akboğa

İnanç

Keskin

et al. 2021

Cardiology in Review

View full text Add to dashboard Cite

show abstract

“…Asimismo, se ha reportado una asociación con la hipertensión pulmonar (HP), asociada a un gasto cardíaco aumentado, el estado hiperdinámico y el ventrículo OR: 3,9) y riesgo alto de mortalidad (OR: 14,3) veces más que los eutiroideos. Concluyendo que la prevalencia de hipotiroidismo en pacientes con SCA fue mayor, lo que predispone a una depresión en la FEVI y mayor riesgo de mortalidad (27).…”

Section: Disfunción Tiroidea Y Corazón: Una Revisión De La Literaturaunclassified

Disfunción tiroidea y corazón: una revisión de la literatura

Blacio Reyes,

Vásquez Calle,

Calle Pallchisaca

et al. 2023

Investigación Contemporánea Desde Una Visión Multdisciplinar. Libro 3. Ciencias De La Salud

View full text Add to dashboard Cite

Analysis of Risk Factors for New Atrial Fibrillation after Coronary Artery Bypass Grafting and Its Influence on Prognosis

佟

2024

ACM

View full text Add to dashboard Cite

The relationship between history of thyroid diseases and risk of in-hospital cardiovascular outcomes in patients with atrial fibrillation: Findings From the CCC-AF (Improving Care for Cardiovascular Disease in China-Atrial Fibrillation) Project

Cited by 4 publications

References 24 publications

Current Evidence on Prevention of Atrial Fibrillation: Modifiable Risk Factors and the Effects of Risk Factor Intervention

Current Evidence on Prevention of Atrial Fibrillation: Modifiable Risk Factors and the Effects of Risk Factor Intervention

Disfunción tiroidea y corazón: una revisión de la literatura

Analysis of Risk Factors for New Atrial Fibrillation after Coronary Artery Bypass Grafting and Its Influence on Prognosis

Contact Info

Product

Resources

About